1Yamada T, Matsumori A, Sasayama S. Therapeutic effect of antitumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation,1994.89(2) :846.
2Atida T, Correlation with disease severity and cardiac autoantibodies. Circulation, 1994,89(3):1120.
3Matsumori A.Yamada T,Maroba Y,et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J.1994,72:561
4Krakauer T. Independent and synergistic thymocyte proliferative activities of PMA and IL 1. J. Immunot,1982,129:939.
7[1]Kalra DK,Zhu X,Ramchandani MK,et al.Increased myocardial gene expression of tumor necrosis factor-α and nitric oxide synthase-2,a potential mechanism for depressed myocardial function in hibernating myocardium in humans[J].Circulation,2002,105(13):1537-1540.
8[3]Nakano M,Knowlton AA,Dibbs Z,et al.Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte[J].Circulation,1998,97(14):1392-1400.
9[4]Torre-Amione G,Kapadia S,Lee J,et al.Expression and functional significance of tumor necrosis factor receptors in human myocardium[J].Circulation,1995,92(6):1487-1493.
10[6]Behnam SM,Behnam SE,Koo JY.TNF-alpha inhibitors and congestive heart failure[J].Skinmed,2005,4(6):363-368.
